FDA Approved: RISPERIDONE — Supplemental Application (Janssen Pharmaceutical, Inc.)

View source ↗

Summary

The FDA approved Janssen Pharmaceutical, Inc.'s supplemental application for risperidone, resulting in updated labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder
• Bipolar Disorder
• Schizophrenia

Drugs mentioned

• Risperdal (risperidone)

Snippet

SUPPL AP for RISPERIDONE (RISPERIDONE)